CompaniesThe objective of the OneMedForum is to showcase the most promising private and micro-cap companies actively seeking capital or partnering opportunities. OneMedPlace thanks its network of advisors for assisting us to identify and invite companies with great potential. Click here to apply to present. |
OneMedForum SF 2012 Presenting Companies
| Company | Description | Recent News |
 2B Blackbio - *No Longer in Business* (Private) [Private Biotech/Device] | Diagnostic products for oncology, pharmacogenetics, and other therapeutic areas >>> Video Profile | |
2B Blackbio - *No Longer in Business* (Private) [Private Biotech/Device] | BlackBio's target is to lead the research and development of new tools in the field of personalized medicine, medical diagnostics and pharmacogenomics. >>> Video Profile | BlackBio gets more than 2 million euros after capital increase and public funding 3B Blackbio Biotech India Manufacturing Plant, India |
 A.P. Pharma (PINK: APPA) [Micro-Cap Biotech/Device] | A.P. Pharma, Inc. is a specialty pharmaceutical company focused on the development of pharmaceutical products utilizing its proprietary polymer-based drug delivery systems. >>> Video Profile | A.P. Pharma to Raise $24 Million in Private Placement of Common Stock and Warrants A.P. Pharma Announces Financing Of Up To $4.5 Million And Names CEO And COO |
| View Profile Acasti Pharma Inc. (APO.V: TSXV) [Micro-Cap Biotech/Device] | Developing pharmaceutical and medical applications for Neptune Krill Oil >>> Video Profile | |
 Access Pharmaceuticals (OTC: ACCP.OB) [Micro-Cap Biotech/Device] | Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products include ProLindac, currently in Phase II clinical testing of patients with ovarian cancer, and MuGard for the management of patients with mucositis. >>> Video Profile | |
 AccuGenomics Inc. (private: private) [Micro-Cap Biotech/Device] | Gene expression tests for cancer diagnosis and treatment | |
 Active Implants Corporation (Private) [Private Biotech/Device] | Orthopaedic medical device company using biological and engineering concepts to create a pliable implant infrastructure that closely emulates skeletal biomechanics, optimally translating the forces produced by normal activity. Intellectual property focused on implant solutions and minimally invasive surgery technology. | |
 ADS Biotechnology, Ltd. (Private) [Private Biotech/Device] | ADS biotechnology is a specialty biopharmaceutical company that is developing a breakthrough, first-in-class blood volume expander that can safely and effectively treat capillary leak syndrome (CLS). >>> Video Profile | |
 Advanced Cardiac Therapeutics (Private) [Private Biotech/Device] | Advanced irrigated cardiac catheter ablation systems | |
 Advaxis Incorporated (OTC BB: ADXSE.OB) [Micro-Cap Biotech/Device] | Develops biotechnology to treat cancer and infectious disease. >>> Video Profile | |
Advaxis Incorporated (OTC BB: ADXSE.OB) [Micro-Cap Biotech/Device] | Advaxis is a live Listeria monocytogenes vaccine company. It has been found that the unique microbe Listeria monocytogenes is capable of stimulating numerous aspects of the immune system simultaneously; including innate immunity, both arms of the adaptive immune response, as well as many non-classical immune responses. >>> Video Profile | Advaxis Receives Additional Financing Advaxis Announces Notice of Allowance of US Patent for ADXS-HPV Immunotherapy |
 Agenus (NASDAQ: AGEN) [Micro-Cap Biotech/Device] | Therapeutics addressing infectious diseases, auto-immune disease and cancer. >>> Video Profile | |
 Aleva Neurotherapeutics (Private) [Private Biotech/Device] | Implants for deep brain stimulation therapies | |
| View Profile Antisense Pharma (Private) [Private Biotech/Device] | Drugs which block key proteins responsible for the onset and progression of cancer. | |
| View Profile APICA Cardiovascular Ltd. (Private) [Private Biotech/Device] | Manufactures cardiovascular devices | |
| View Profile AssureRx (Private) [Private Biotech/Device] | The first psychiatric pharmacogenetic product from AssureRx Health uses state-of-the-art technology to measure and analyze clinically important genetic variants affecting response to psychiatric medications in individual patients. The results of the test can help a clinician understand the way a patient's unique genetic makeup can affect how certain psychiatric drugs work for each individual. The analysis is based on pharmacogenetics, FDA-approved manufacturer's drug labels, scientifically valid published reports, and proven pharmacology. | Personalized Medicine Innovator AssureRx Health Selects Community Center for Expansion in Mason, Ohio AssureRx Health Expands Senior Management Team to Support and Accelerate Business Growth |
 Avita Medical Ltd. (ASX: AVH.AX) [Micro-Cap Biotech/Device] | Avita Medical, formerly known as Clinical Cell Culture (C3), was established to commercialize tissue engineered products for autologous cell replacement. >>> Video Profile | 'Spray-On Skin' Company Ramps Up Global Expansion Cell Harvesting Device for Vitiligo Treatment |
 Bacterin International (NYSE Amex: BONE) [Micro-Cap Biotech/Device] | Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products. >>> Video Profile | Bacterin Becomes Premier Founding Sponsor of RMEC's New Osteobiologics Registry Bacterin to Present at Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011 |
Bacterin International (NYSE Amex: BONE) [Micro-Cap Biotech/Device] | Bone graft material and anti-infective coatings for medical applications >>> Video Profile | |
 Biocept Laboratories (Private) [Private Biotech/Device] | Biocept's polyethylene glycol-based urethane hydrogel technology platform is versatile in that it enables microarrays for both genomic and proteomic applications. Biocept's platform combines its core competencies in hydrogel polymers and organic chemistry, enabling Biocept to make microarrays in which each spot is a hemispherical microdroplet. | Biocept, Inc. announces key patent allowance for the CEE microfluidic channel for Circulating Tumor Cells Biocept Publishes on Mechanics and Performance of its OncoCEE Platform for Circulating Tumor Cells (CTCs) in Cancer Patients |
 Biovista, Inc. (Private) [Private Biotech/Device] | Biovista is a biopharmaceutical company that systematically repurposes drugs for unmet medical needs in commercially valuable indications. >>> Video Profile | Biovista to present at the Drug Repositioning Conference Biovista Announces Research Collaboration With a Major Pharmaceutical Company |
 BMEYE (Private) [Private Biotech/Device] | BMEYE is a provider of non-invasive, beat-to-beat, user-friendly cardiovascular monitoring systems, to improve patient care and reduce healthcare costs. >>> Video Profile | Perioperative monitoring and optimization by totally non-invasive cardiac output measurement Getting To The Heart Of Down Syndrome With The Help Of Flies And Mice |
| View Profile BrainScope Company, Inc. (Private) [Private Biotech/Device] | Devices to assess traumatic brain injury at the initial point of care. | |
| View Profile CADENS Imaging (PRIVATE: PRIVATE) [Micro-Cap Biotech/Device] | CADENS Imaging develops state-of-the-art imaging solutions dedicated to supporting non-invasive cancer screening. | |
 Capricor, Inc (private: private) [Micro-Cap Biotech/Device] | Heart-derived stem cells for cardiac regeneration | |
Capricor, Inc (private: private) [Micro-Cap Biotech/Device] | Capricor is a biotechnology company focused on developing and commercializing powerful cardiac stem cell treatments to regenerate the heart. Capricor's aim is to transform the treatment of heart disease, bringing an ingenious approach to cardiac medicine and stem cell technology. | |
| View Profile Caprion Proteomics (Private) [Private Biotech/Device] | Industrialized proteomics for clinical and pre-clinical testing | |
| View Profile Caprion Proteomics (Private) [Private Biotech/Device] | Caprion Proteomics is the leading provider of proteomics based services to the pharmaceutical industry. Combines distinctive capabilities in biological sample collection and preparation, cell fractionation, mass spectrometry and bioinformatics data analysis in a manner that enables a comprehensive, quantitative and robust measurement of the protein expression differences across large sets of biological samples. | Caprion Protéomique: la rentabilité avant les découvertes Caprion Proteomics identifies promising new candidate biomarkers to predict response to hepatitis C treatment |
 Cardium Therapeutics (AMEX: CXM) [Micro-Cap Biotech/Device] | Cardium Therapeutics is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs. >>> Video Profile | Cardium Provides Update on Exchange Listing and Related Business Matters Cardium Announces Receipt of $1.1 Million in Funds from Philips' Acquisition of Innercool Therapies |
 Castlewood Surgical (Private) [Private Biotech/Device] | Castlewood Surgical, Inc. is a medical device company that is committed to improving the care of patients with cardiovascular disease. Their mission is to leverage physician and engineering innovation to improve patient outcomes while operating an efficient business driving toward profitability. >>> Video Profile | First Human use of an Allogeneic Tissue Engineered Vascular Graft Bioengineered Arteriovenous Grafts |
 CeQur (Private) [Private Biotech/Device] | CeQur is an insulin delivery device company, developing and commercializing a small, discrete, and uniquely simple insulin delivery device for people with type 2 diabetes. The Company was established in January 2008 as a spin-out from Danfoss A/S, a large, global, Danish industrial products group that had developed the core technology, product concept and early prototypes. CeQur is a Swiss-registered private company with operations in Denmark and Marlborough, MA, USA. >>> Video Profile | |
 Cervilenz Inc (Private) [Private Biotech/Device] | Cervical length measurement to determine risk of preterm birth >>> Video Profile | |
Cervilenz Inc (Private) [Private Biotech/Device] | Cervilenz Inc. is an innovative medical device that measures cervical length to help identify and manage pregnant women at high risk for preterm birth. CerviLenz is ready to support this new clinical need for cervical length measurement to help reduce the incidence and cost of prematurity. Cervilenz Inc. has an experienced executive team led by Dean Koch, formerly Vice President of Marketing at Adeza Biomedical which was the pioneer in preterm birth diagnostics and therapeutics. >>> Video Profile | Industry Veteran, Eileen Maus, Joins Cervilenz Inc. Board of Directors Cervilenz Inc. Sponsored 2011 ACNM Annual Meeting |
 Colby Pharmaceutical Company (Private) [Private Biotech/Device] | Colby has developed new signal transduction, oxidative-stress and hypoxia inhibitor drugs for treatment of prostate and other solid tumors which restore normoxia and therapy-sensitivity. >>> Video Profile | |
 CorInnova Incorporated (Private) [Private Biotech/Device] | Develops cardiological devices. | |
CorInnova Incorporated (Private) [Private Biotech/Device] | Corinnova Incorporated founded in 2004 in College Station. Texas, is an early sage. medical deice company that is engaged in the transfer of innovative lifesaving technology from the laboratory of Dr. John C. Criscione at Texas A&M University. | |
 CVAC Systems, Inc. (private: private) [Micro-Cap Biotech/Device] | CVAC Systems is a developer of the patent-pending Cyclic Variations in Altitude Conditioning technology, which markets for wellness and athletic conditioning. >>> Video Profile | Effort-free Physical Conditioning Technology Shows Promise for Certain Chronic Pain Sufferers CVAC Systems, Inc. and Compass Equity Group Inc. Announce Leasing Agreement |
 Cyclacel Pharmaceuticals (NASDAQ: CYCC) [Micro-Cap Biotech/Device] | Cyclacel is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. By targeting the cell cycle that underlies cell proliferation, Cyclacel's drugs function stops the uncontrolled cell growth seen in cancer. >>> Video Profile | Cyclacel to announce third quarter 2011 financial results and upcoming corporate events Cyclacel to present at BIO Investor Forum |
| View Profile Cytograft Tissue Engineering (private: private) [Micro-Cap Biotech/Device] | Cytograft's vision is to revolutionize cardiovascular medicine by developing cell-based therapies to repair and rebuild diseased tissues and organs without using synthetic biomaterials. | Engineers create human blood vessels from skin cells Cytograft publishes an article in Endovascular Today |
 CytoSorbents Corporation (OTCBB: CTSO) [Micro-Cap Biotech/Device] | CytoSorbents is a medical device company that has developed a state-of-the-art hemoperfusion technology that serves to remove toxins and deleterious components from the blood for treatment of serious medical conditions including sepsis and kidney disease. >>> Video Profile | CytoSorbents Corporation to Exhibit at the European Society of Intensive Care Medicine Congress in Berlin and at the AdvaMed Conference in Washington D.C. CytoSorbents Announces New Statistical Analysis and Confirms Statistical Significance in 28-Day Mortality |
 DATATRAK International (OTCQX: DATA.PK) [Micro-Cap Biotech/Device] | DataTrak is a prominent software technology company that has developed leading-edge eClinical solutions for the electronic data capture healthcare field, particularly for clinical trials. >>> Video Profile | DATATRAK and CRO Connect Partner, Tigermed, Deploy Chinese Study Cardiovascular CRO Selects DATATRAK ONE |
 Del Mar Pharmaceuticals (OTC BB: DMPI.OB) [Micro-Cap Biotech/Device] | Del Mar Pharmaceuticals' mission is to build shareholder value by rapidly developing and commercializing proven anti-cancer therapies in orphan indications where patients have failed modern biologic therapy. >>> Video Profile | Del Mar Pharma Announces Initiation of Glioblastoma Study DelMar Pharmaceuticals receives FDA IND Approval to begin clinical trials with a new brain cancer treatment |
 EpiCept Corporation (OTC: EPCT.PK.OB) [Micro-Cap Biotech/Device] | EpiCept is a biopharmaceutical company that has established a diverse drug development platform to actualize therapeutics indicated for the treatment of cancer and neuropathic pain. >>> Video Profile | EpiCept Corporation Reports Third Quarter 2011 Operating and Financial Results EpiCept Common Stock to Begin Trading on OTCQX, The Highest Tier of the OTC Market, on September 19, 2011 |
| View Profile Evofem (Private) [Private Biotech/Device] | Evofem is involved in the development of a broad area of pharmaceutical and OTC products including: vaginal microbicides to protect women against unwanted pregnancies and sexually transmitted diseases including the AIDS virus, topical OTC products for treating itch, burn and sting, and Rx topical neuropathic pain drugs. Evofem is in Phase III contraceptive trials with its Amphora vaginal gel. | |
 Fibrocell Science (OTCBB: FCSC.OB) [Micro-Cap Biotech/Device] | Develops personalized cell therapies for aesthetic, medical, and scientific applications >>> Video Profile | |
Fibrocell Science (OTCBB: FCSC.OB) [Micro-Cap Biotech/Device] | Fibrocell Science, Inc. is a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications. >>> Video Profile | Studies Show LAVIV (azficel-T) Effectively Improves the Appearance of Smile Line Wrinkles LAVIV (azficel-T) Demonstrates Improvement in Acne Scarring |
 Functional Neuromodulation (private: private) [Micro-Cap Biotech/Device] | Deep brain stimulation for Alzheimerâ??s | |
Functional Neuromodulation (private: private) [Micro-Cap Biotech/Device] | Deep brain stimulation for Alzheimerâ??s | |
 Genomic Expression Inc (Private) [Private Biotech/Device] | Colby has developed new signal transduction, oxidative-stress and hypoxia inhibitor drugs for treatment of prostate and other solid tumors which restore normoxia and therapy-sensitivity. >>> Video Profile | |
 Genta Incorporated (OTC BB: GNTA.OB.OB) [Micro-Cap Biotech/Device] | Cancer treatments >>> Video Profile | |
Genta Incorporated (OTC BB: GNTA.OB.OB) [Micro-Cap Biotech/Device] | Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform : DNA/RNA-based Medicines and Small Molecules. >>> Video Profile | Genta Incorporated to Host Conference Call to Discuss Third Quarter 2011 Highlights and Financial Results Genta Completes Financing of up to $12.7 Million |
 GlySure (Private) [Private Biotech/Device] | Glysure is a medical devices company that has developed a technological platform for continuous glucose monitoring in diabetic patients. The company?s technology utilizes a proprietary intravascular fluorescent-based sensor. >>> Video Profile | Clinical Data Glysure Ltd and Technomark Life Sciences Sign Partnership Agreement for Clinical |
 Hepregen (Private) [Private Biotech/Device] | Hepregen is a biotechnology company that has pioneered a breakthrough biological platform that enables high-fidelity laboratory studies of liver function, including liver drug toxicity testing and drug discovery analysis. >>> Video Profile | HepatoPac Liver Model is Touted for its Value to Predict Clinical Parameters of Commercially Available Drugs Company receives $500,000 grant; continues growth through adoption of its microliver platform, HepatoPac, by leading biopharmaceutical companies |
 Histogenics, Inc (Private) [Private Biotech/Device] | Autologous neocartilage for tissue repair >>> Video Profile | |
Histogenics, Inc (Private) [Private Biotech/Device] | Histogenics Corporation is a privately held regenerative medicine company that combines a rich portfolio of cell therapy and tissue engineering technologies to develop highly innovative products for tissue repair and regeneration. The Company's flagship products focus on the treatment of active patients suffering from articular cartilage derived pain and immobility. >>> Video Profile | Histogenics Appoints Scientific Advisory Board Comprised of Regenerative Medicine Leaders Histogenics Appoints Industry Veterans to Support NeoCart Phase 3 Clinical Development |
 HistoSonics, Inc. (private: private) [Micro-Cap Biotech/Device] | Cavitation via ultrasound to treat benign prostatic hyperplasia | |
 HyGreen, Inc. (Private) [Private Biotech/Device] | HyGreen, Inc. is an innovative technology company whose mission is to improve lives by safeguarding health through technology. Its HyGreen Hand Hygiene product provides hospitals, skilled nursing facilities, doctor's offices, restaurants and educational institutions with the tools to measure hand hygiene, improve hand hygiene behaviors, increase facility quality, and decrease infection control costs. |
HyGreen Called to Washington to Share Solution for Hospital Acquired Infection HyGreen Nominated for World Technology Award |
 ImmunoGenetix Therapeutics (Private) [Private Biotech/Device] | ImmunoGenetix Therapeutics is a biotech company that is developing powerful therapeutic DNA vaccines that serve to actively induce a potent physiological immune response against and for the treatment of infectious diseases >>> Video Profile | ImmunoGenetix to present at The 5th Annual OneMedForum San Francisco 2012 Market Formula: ImmunoGenetix Takes a Unique Path To Get Its Anti-HIV Drug To Consumers |
 InfoBionic (private: private) [Micro-Cap Biotech/Device] | Cloud-based solution for remote physiological monitoring. | |
InfoBionic (private: private) [Micro-Cap Biotech/Device] | InfoBionic is a cloud based solution for comprehensive remote physiological monitoring with a focus on Arrhythmia Detection. InfoBionic uses the cloud to gather data from multiple parameters including ECG, respiration, SpO2, and blood pressure and analyzes them with sophisticated and proprietary algorithms. This is in marked contrast to manual delivery of devices to gather ECG data, or local processing on smartphones or other devices with limited and fixed processing capabilities. | |
| View Profile Infonaut Inc. (private: private) [Micro-Cap Biotech/Device] | Accumulation and refinement of data for expedient decision-making | |
| View Profile Infonaut Inc. (private: private) [Micro-Cap Biotech/Device] | Infonaut fills a critical gap in the resources available to healthcare planners: with a map-based GIS tool that supports fast, information-rich decisions. Infonaut specializes in taking overwhelming volumes and types of data, refining it, and representing it in an intuitive way. We filter out the noise and give decision-makers what they actually need: easy-to-use, easy-to-read, decision support solutions. Making information informative. | |
| View Profile InfuSystem Holdings, Inc. (NYSEAMEX: INFU) [Micro-Cap Biotech/Device] | supplier of infusion services to oncologists and other outpatient treatment settings. The company provides pole mounted and ambulatory pumps, supplies and related clinical, biomedical and billing services to practices and patients. | |
 IntelGenx Corp. (OTCQX: IGXT) [Micro-Cap Biotech/Device] | Drug delivery company focusing on oral drug delivery >>> Video Profile | |
 Intellect Neurosciences (OTC: ILNS.PK.OB) [Micro-Cap Biotech/Device] | \Disease-modifying\ drugs designed to ultimately prevent serious neurological disorders >>> Video Profile | |
Intellect Neurosciences (OTC: ILNS.PK.OB) [Micro-Cap Biotech/Device] | Intellect Neurosciences, Inc. is a Manhattan-based development-stage biopharmaceutical company pioneering the discovery and development of innovative approaches to address the large and unmet clinical need for drugs that can slow down, arrest and ultimately prevent Alzheimer's disease. >>> Video Profile |
Intellect Neurosciences Obtains Two New Patents in Japan for its Alzheimer's Immunotherapy Programs Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN Alzheimer's Patent Application |
 Interface Biologics, Inc. (Private) [Private Biotech/Device] | IBI is a privately held commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. | Interface Biologics announces Licensing Agreement with Navilyst Medical Fresenius Medical Care Executes Exclusive Interface Biologics License Agreement |
| View Profile Invuity (Private) [Private Biotech/Device] | Visualization for less invasive surgeries | |
| View Profile ISCHEM Corporation (Private) [Private Biotech/Device] | Identification and management of vulnerable plaque. | |
| View Profile ISCHEM Corporation (Private) [Private Biotech/Device] | Identification and management of vulnerable plaque. | |
 IsoRay Medical (AMEX: ISR) [Micro-Cap Biotech/Device] | Cancer treatments using Cesium 131 radioisotope...
Currently treating-
Brain cancers- Glio, Mets and Mengi
Head and Neck cancer
Lung cancer- Primary and Mets
Colon Cancer
Prostate Cancer
Ocular cancer >>> Video Profile | |
| View Profile Life Medical Technologies, Inc. (private: private) [Micro-Cap Biotech/Device] | Life Medical Technologies is dedicated to educating and providing life-enhancing, innovative medical products to bring about a successful outcome in the fight against breast cancer and other life-threatening illnesses. | |
 LoneStar Heart (Private) [Private Biotech/Device] | LoneStar Heart, Inc. (formerly CardioPolymers) is a Texas and California based biomedical company developing new therapies to preserve and restore adequate heart function in patients with Congestive Heart Failure (CHF). >>> Video Profile | UTSW, LoneStar Heart Team Up For Research |
 Mast Therapeutics, Inc. (NYSE MKT: ANX) [Micro-Cap Biotech/Device] | Adventrx is a specialty pharmaceutical company that focuses on drug reformulation of currently used drugs to develop enhanced medications, particularly for cancer. >>> Video Profile | ADVENTRX and FDA Reach Agreement on Pivotal Study for ANX-514 ADVENTRX Provides Update on All Three Pipeline Products |
Mast Therapeutics, Inc. (NYSE MKT: ANX) [Micro-Cap Biotech/Device] | Hematology and oncology-focused biopharmaceutical company with three clinical-stage product candidates. >>> Video Profile | |
 MEDomics (Private) [Private Biotech/Device] | MEDomics (www.medomics.com) is the leader in Mutation Expert Diagnosis providing NextGen sequence-based DNA diagnostic testing which enables diagnosis and personalized care as the physician's partner in personal genomics. | MEDomics presents TARZAN model at Plant and Animal Genome Conference 2011 MEDomics reports 44-fold Increase in Clinical Testing Sales at the OneMedPlace Investment Forum associated with the JP Morgan Healthcare Conference |
| View Profile Memen Pharmaceuticals (Private: private) [Micro-Cap Biotech/Device] | Treatment for diseases of the central nervous system | |
 Microvisk Limited (private: private) [Micro-Cap Biotech/Device] | Microvisk Technologies is a UK based company developing Micro Electro Mechanical Sensors for the international medical market. |
Microvisk introduces World?s First Diagnostic smart strip system in the US Microvisk Announces New Board of Directors ahead of Product Launch |
Microvisk Limited (private: private) [Micro-Cap Biotech/Device] | Time assays to determine rate of blood coagulation | |
Microvisk Limited (private: private) [Micro-Cap Biotech/Device] | Microvisk Technologies is a UK-based company developing Micro Electro Mechanical Sensors for the international medical market. |
Microvisk introduces World's First Diagnostic smart strip system in the US Microvisk Announces New Board of Directors ahead of Product Launch |
 Miracor Medical Systems GmbH (Private) [Private Biotech/Device] | Develops technology to improve outcome after heart attacks. | |
Miracor Medical Systems GmbH (Private) [Private Biotech/Device] | Miracor has developed a unique technology platform addressing large unmet clinical needs in acute coronary syndrome, heart failure and cardiac surgery patients. The company's proprietary system, the Miracor PICSO, is the only technology that addresses the whole venous vasculature with the potential to clear the microcirculation and revitalize the heart tissue (myocardium) after a heart attack. | Miracor to report successful clinical study results of its PICSO system designed to improve myocardial perfusion following primary PCI Miracor Secures $10M in Series B Financing Round |
 Mirna Therapeutics, Inc. (Private) [Private Biotech/Device] | Mirna Therapeutics, Inc. (Mirna) is a biopharmaceutical biotechnology research and development company focused on miRNA-directed oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology. | Bacterin Becomes Premier Founding Sponsor of RMEC's New Osteobiologics Registry Mirna Therapeutics: Delivering on microRNA cancer therapy |
 Nanospectra Biosciences (Private) [Private Biotech/Device] | Nanospectra Biosciences is a clinical stage, private company commercializing
AuroLase Therapy for the selective and precise thermal destruction of solid tumors. | |
 NanoViricides, Inc. (OTCBB: NNVC) [Micro-Cap Biotech/Device] | Works in the area of targeted anti-viral therapeutics. Utilizing nanoscale materials and processes licensed from TheraCour Pharma, Inc., they are developing anti-viral drugs against a wide range range of human and animal viruses. >>> Video Profile | NanoViricides Raises an Additional $5 Million in Shelf Offering - The Company Reports Having More than 24 Months of Cash in Hand NanoViricides' Anti-Virus Technology Published in Bionanotechnology II: Global Prospects |
| View Profile Neodyne Biosciences (Private) [Private Biotech/Device] | Tissue repair to minimize scar formation | |
 NeoGenomics (OTC: NGNM.OB) [Micro-Cap Biotech/Device] | NeoGenomics is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. >>> Video Profile | NeoGenomics Reports Third Quarter 2011 Results NeoGenomics to Present at the Rodman & Renshaw Healthcare Investment Conference on September 12, 2011 |
 Neovasc, Inc. (TSXV: NVC.V) [Micro-Cap Biotech/Device] | Neovasc manufactures biological tissue for incorporation into devices such as transcatheter heart valves and develops products to treat vascular disease, including the reducer device that is currently in pivotal clinical trials for the treatment of refractory angina. >>> Video Profile | Neovasc to Present at Lazard Capital Markets 8th Annual Healthcare Conference Neovasc Reports Financial Results for Third Quarter of 2011 |
 NeuroMetrix (NASDAQCM: NURO) [Micro-Cap Biotech/Device] | Diagnosis and treatment of neurological complications of diabetes. >>> Video Profile | |
 Northwest Biotherapeutics (OTCBB: NWBO.OB) [Micro-Cap Biotech/Device] | Immunotherapy products for cancer treatment >>> Video Profile | |
| View Profile Nova Nano Diagnostics (private: private) [Micro-Cap Biotech/Device] | Ultrasensitive nanoparticles that identify biomarkers | |
 Novadaq Technologies Inc. (TSX: NDQ.TO) [Micro-Cap Biotech/Device] | Novadaq Technologies develops and markets real-time fluorescence imaging technologies for use in the operating room. The Company's technology platform, SPY Imaging, provides clinically relevant, anatomic and physiological images during invasive surgical procedures. >>> Video Profile | Novadaq Reports Third Quarter 2011 Financial Results Novadaq to Present at November Investor Healthcare Conferences |
| View Profile Novocell (Private: private) [Micro-Cap Biotech/Device] | Cellular encapsulation and islet cell transplantation for the treatment of diabetes. | |
 OncoSec Medical (OTCBB: ONCS) [Micro-Cap Biotech/Device] | OncoSec Medical Incorporated (ONCS) develops novel cancer therapeutic products that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics. >>> Video Profile | Device Master File for OncoSec Medical System Completed and Submitted to FDA OncoSec Releases Devices For Use In Clinical Trials |
 PLC Medical Systems Inc. (OTC BB: PLCSF.OB) [Micro-Cap Biotech/Device] | PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. >>> Video Profile | PLC Systems' RenalGuard to be Featured in Chronic Kidney Disease and Contrast Nephropathy Session at TCT 2011 PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S. |
PLC Medical Systems Inc. (OTC BB: PLCSF.OB) [Micro-Cap Biotech/Device] | Technologies for cardiac and vascular markets, prevention of CIN >>> Video Profile | |
| View Profile Precision Nanosystems (private: private) [Micro-Cap Biotech/Device] | Precision NanoSystems has developed proprietary microfluidic devices for simple, rapid, reproducible and cost-effective manufacture of next-generation lipid nanoparticles. | |
| View Profile Radlogics (private: private) [Micro-Cap Biotech/Device] | RadLogics is a providing a Software-as-a-Services solution for radiologists that substantially improve their accuracy and productivity in reading and reporting CT cases. RadLogics\'s AlphaPoint(tm) software platform has been tested to seamlessly integrate with existing radiology IT infrastructure, and is in the process of getting FDA 510(k) class 2 clearance. | |
| View Profile Radlogics (private: private) [Micro-Cap Biotech/Device] | Software solution for radiologistsâ?? CT reports | |
| View Profile Ratio, Inc. (Private) [Private Biotech/Device] | Expanding polymer hydrogel pump-patch for improved drug delivery | |
 Ridge Diagnostics, Inc. (private: private) [Micro-Cap Biotech/Device] | Neurodiagnostic Blood Tests for Major Depressive Disorder | |
Ridge Diagnostics, Inc. (private: private) [Micro-Cap Biotech/Device] | Ridge Diagnostics is a neurodiagnostic company developing and marketing a portfolio of blood-based tests for neuropsychiatric disorders. The product is a first-in-class, proprietary blood test for clinical depression, or Major Depressive Disorder (MDD). This breakthrough diagnostic is the first blood-based test to aid in the diagnosis, management and monitoring of a neuropsychiatric disease. | Ridge Diagnostics Uses Social Media to Educate about Blood Test for Depression Ridge Diagnostics Depression Blood Test Biomarker Technology featured in Cover Story of Psychiatric Times |
 Rubigo Therapeutics (Private) [Private Biotech/Device] | Rubigo Therapeutics is a development stage company focused on a combination product to deliver an FDA approved, now generic immune response modifying drug through a proprietary polymeric material that enables improved control and direction delivery of the therapeutic molecule. >>> Video Profile | |
 S.E.A. Medical Systems, Inc. (Private) [Private Biotech/Device] | S.E.A. Medical Systems, Inc. is pioneering smart solutions for safe manufacture, preparation, delivery and disposal of IV and other liquid medications. The company is placing its disruptive technology into product systems that instantly detect drug, concentration and diluent using consumable sensors. >>> Video Profile | SEA Medical Systems adapts business strategy in light of proposed FDA changes SEA Medical Systems focuses on stemming hospital drug errors |
| View Profile Smart Perfusion, LLC (Private) [Private Biotech/Device] | System for organ transplant | |
 Soft Tissue Regeneration, Inc. (Private) [Private Biotech/Device] | Soft Tissue Regeneration, Inc. ("STR") has developed and preliminarily tested a potential breakthrough technology for soft tissue regeneration of the anterior cruciate ligament ("ACL") of the knee. >>> Video Profile | Connecticut Innovations (CI) has made a follow-on investment of $750,000 in Soft Tissue Regeneration Inc Dr. Cato T. Laurencin, Scientific Founder of Soft Tissue Regeneration, Inc Has Been Elected To The Prestigious National Academy of Engineering |
 SpectraScience (.PK: SCIE) [Micro-Cap Biotech/Device] | SpectraScience, Inc. focuses on developing the WavSTAT Optical Biopsy System (WavSTAT System), a minimally invasive spectroscopic system that optically scans tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue, without the need to remove tissue from the body. >>> Video Profile | SpectraScience to Introduce WavSTAT4 Optical Biopsy System at United European Gastroenterology Week SpectraScience Strengthens Intellectual Property Portfolio |
 Spherix Incorporated (Nasdaq: SPEX) [Micro-Cap Biotech/Device] | Spherix is small, clinical-stage, biotech company dedicated to development of Tagatose as a treatment for Type 2 Diabetes and Hypertriglyceridemia. Tagatose is an oral small molecule with a novel mechanism of action on glucose and lipid homeostasis. >>> Video Profile | Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceed Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight |
| View Profile Strohl Medical (private: private) [Micro-Cap Biotech/Device] | Strohl Medical Technologies, Inc. is building a business to provide accurate and timely neurophysiologic data to assist E.R. docs and Neurologists in better triaging potential stroke patients. | |
 Symetis S.A. (Private) [Private Biotech/Device] | Symetis SA is a private Swiss company developing innovative, minimally invasive heart valve replacement solutions. The company's products, ACURATE TATM and ACURATE TFTM, based on proprietary geometry and delivery technologies, are well positioned to target the estimated $2 billion TAVI market. | Symetis' ACURATE TA Aortic Bioprosthesis Receives CE Mark Certification on Sept. 30th 2011 Symetis reports on its trans-apical ACURATE TA clinical development |
 Telik, Inc. (NASDAQ: TELK) [Micro-Cap Biotech/Device] | Small molecule drugs to treat cancer >>> Video Profile | |
| View Profile Thermalin Diabetes, LLC (Private) [Private Biotech/Device] | Insulin analogs offering increased effectiveness >>> Video Profile | |
 ThermoGenesis (NasdaqCM: KOOL) [Micro-Cap Biotech/Device] | Thermogenesis is a biotech company that has developed advanced regenerative medicine technology for the processing, preparation, and preservation of stem cells. >>> Video Profile | ThermoGenesis Announces Acceptance of AXP® Submission by Regulatory Body in China ThermoGenesis Reports Fourth Quarter and Year End 2011 Results; Annual Net Loss Reduced by More Than 50 Percent |
 TONIX Pharmaceuticals Holding Corp. (OTC BB: TNXP.OB) [Micro-Cap Biotech/Device] | TONIX Pharmaceuticals is developing high-value prescription therapeutics for chronic Central Nervous System (CNS) conditions, such as Fibromyalgia Syndrome and Post-Traumatic Stress Disorder. >>> Video Profile | TONIX Pharmaceuticals and Tamandare Explorations Announce Completion of Share Exchange Transaction and Private Placement TONIX Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology |
 Vigilant Biosciences (private: private) [Micro-Cap Biotech/Device] | Vigilant Biosciences is developing innovative products to enable early intervention to improve health and modify potentially adverse health outcomes. | Publications |
 VisionCare Ophthalmic Technologies, Inc. (Private) [Private Biotech/Device] | VisionCare Ophthalmic Technologies is focused on the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision. | First Patient Receives FDA-Approved Telescope Implant for End-Stage Macular Degeneration Medicare Establishes Reimbursement for VisionCare's Implantable Telescope for Macular Degeneration |
| View Profile VisionGate (Private) [Private Biotech/Device] | Early cancer detection through 3-D cell-imaging | |
 Wafergen Biosystems (OTC: WGBS.OB) [Micro-Cap Biotech/Device] | WaferGen Biosystems, Inc., provides genomics analysis solutions from research to clinic for the life science and pharmaceutical industries. Its high-throughput, nano-scale genomics solutions are designed to revolutionize disease research. >>> Video Profile | WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System WaferGen SmartChip System Chosen to Confirm Accuracy of Blood Test for Cancer |
 Wound Management Technologies Inc (OTC: WNDM.OB) [Micro-Cap Biotech/Device] | Wound Management Technologies is a biotech company that has developed a superior, FDA-approved wound healing therapeutic that is active in all phases of wound healing. >>> Video Profile | Wound Management Technologies to Present at AdvaMed 2011 Military Shopping Channel to Offer CellerateRX to its 10M+ Eligible Members; WNDM Product Sales on Military Site to Commence September 1, 2011 |
Presenting Companies from Past OneMedForums
• NY Jul 2011 / SF Jan 2011 / NY June 2010 / SF Jan 2010
• Presenting Company Benefits (PDF)